DCI Research

Sydnee Crankshaw, MPA, has been named Senior Research Program Leader for DCI’s "Cancer Prevention and Control" and "Cancer Risk, Detection, and Interception" programs.

After a 30-year career in clinical cancer research nursing at Duke, Susan Boulton, RN, BSN, has announced her retirement, effective October 29. 

New NCCN Guidelines released for basal cell skin cancer, the most common type of cancer. DCI's Rachel Blitzblau, MD, PhD, panel vice-chair, weighs in.

The metastatic breast cancer research grants, made possible by Susan G. Komen, bring together patient advocates and DCI & UNC Lineberger investigators.

A DCI-led research team has identified how melanoma tumors use estrogen signaling to trick the immune system into leaving them alone.

Study led by Tomi Akinyemiju, PhD, finds racial disparities in lung cancer outcomes erased by equal access to top treatments.

The gloves are on in the fight against breast cancer. See you at sunrise, Oct. 23 !

The $3 million National Science Foundation grant is for training Master’s and PhD students at Duke in engineering, computer science, data science, & surgical technologies.

Duke Cancer Institute member Joseph Heitman, MD, PhD, has been elected to the German National Academy of Sciences Leopoldina.

Dukes receives two large grants totaling nearly $12 million from the National Human Genome Research Institute (NHGRI) as part of its new Impact of Genomic Variation on Function (IGVF) Consortium.

The event, which also featured talks from Henrietta Lacks’ great-granddaughter and a bioethics leader at Tuskegee University, drew more than 750 viewers worldwide.

Hai Yan, MD, PhD, was awarded the International Prize for Translational Neuroscience for identifying genetic mutations linked to gliomas.

New study on cholesterol and breast cancer finds link between high cholesterol and worsening cancer spread.

Shelley Hwang, MD, vice chair of Research in the Department of Surgery, is renowned for her work in pre-invasive breast cancer.

The $1.25 million grant from the Cancer Research Institute will support brain tumor immunotherapy research

Cheyenne Corbett, PhD, with DCI's Supportive Care & Survivorship Center and Center for Onco-Primary Care, weighs in on the findings.

DCI molecular biologist Jason Somarelli, PhD, utilizes comparative and evolutionary biology in his cancer research.

J. Michael Cook, PhD, assistant professor in the Department of Immunology and co-leader of the Flow Cytometry Shared Resource has passed away.

Cancer deaths were lower in those five states and District of Columbia that expanded Medicaid early-on as part of the Affordable Care Act.

Here are some of the DCI faculty, researchers and nurses whose work has recently been featured by the media, academic trade publications & journals.

An NIH grant awarded to Greg Palmer, PhD, will fund a micro CT/micro irradiator for the Radiation Oncology Research Program.

Christopher Counter, PhD, Devon Noonan, PhD, MPH, Charles Gersbach, PhD, Fang-Fang Yin, PhD, Sue Jinks-Robertson, Deborah Muoio, PhD, awarded distinguished professorships.

Some people fall into their life’s work by serendipity or happenstance. Annick Desjardins, MD, FRCPC, is not one of those people.

Zhao Zhang, PhD, is one of 22 scholars (early-career junior faculty) nationwide this year to receive this 4-year, $300,000 grant award.

DCI scientist Ehsan Samei, PhD, Professor of Radiology, Physics, Biomedical Engineering, and Electrical and Computer Engineering, is director of the Center for Virtual Imaging Trials.

An estimated 10.5% of new diagnoses of colorectal cancer will be in men and women younger than 50. Now there's new screening guidelines.

“I had always considered myself one of the healthiest people I knew ...”

Shanta Laurie Garvin MHSA, MPA, CRA, has joined DCI as director of Research Development-Clinical Research.

After 32 years with the Duke Cancer Institute family, breast medical oncologist P. Kelly Marcom, MD, retired from clinical practice at the end of May.

Brent Hanks, MD, PhD, received the Conquer Cancer- Bristol-Myers Squibb Advanced Clinical Research Award in Immune Checkpoint Therapy.

DCI member Fang-Fang Yin, PhD (left) has been named the Gustavo S. Montana Professor of Radiation Oncology, effective July 1.

Thomas Stinchcombe, MD, and Carey Anders, MD, will assume new leadership roles as James Abbruzzese, MD, steps down from these roles, effective July 1.

Working@Duke spoke with Meenal Kheterpal, MD, who directs Duke Dermatology’s skin cancer research programs, about sun risks and how to keep safe.

Their winning article was published in the Journal of Applied Clinical Medical Physics in April, 2020.

The Duke Cardio-Oncology program hosts a webinar on identifying and managing cardio-toxicities in patients undergoing cancer treatment. CE is available.

Sponsored by Duke Neurosurgery, the Duke Center for Brain & Spine Metastasis launches its inaugural national colloquium June 25 & 26.

DCI investigators led by researcher Gayathri Devi, PhD, awarded a $1.6 million DoD grant to investigate the mechanisms underlying inflammatory breast cancer metastasis.

Renowned DCI neurosurgeon-scientist Peter Fecci, MD, PhD, is one of three SoM faculty members to be inducted this year into ASCI.

DCI oncologists and researchers are supporting the Komen mission “for a cure” — fighting breast cancer on all fronts. Learn about their research.

The DCI Office of Health Equity hosted a clinical trials primer for the community led by Angelo Moore, PhD, RN, in partnership with the Durham Men's Health Council. (5.18)

Astellas Pharma Inc. announced on May 4 that the European Commission has approved enzalutamide for adult men with metastatic hormone-sensitive prostate cancer.

Enrolling a large number of Black men, Duke researchers found potential new paths for improved studies and treatments.

DCI member Joseph Heitman, MD, PhD, chair of the Department of Molecular Genetics and Microbiology, elected to National Academy of Sciences.

DCI faculty Thomas Leblanc, MD, MA, MHS, FAAHPM, has been named a Fellow of the American Society of Clinical Oncology.

DCI faculty Daniel George, MD, has been named a Fellow of the American Society of Clinical Oncology.

This OHE-hosted talk featured director of the Patierno/George/Freedman Lab Jennifer Freedman, PhD, and postdocs Tyler Allen, PhD, and Sean Piwarski, PhD.

Four DCI head & neck oncology specialists highlight advances in diagnosis, treatment, clinical trials in surgical oncology, radiation oncology, and medical oncology.

Research led by Duke Cancer Institute’s Jen-Tsan Ashley Chi, MD, PhD, could have implications for the successful treatment of ovarian, breast and kidney cancer.

Various genetic alterations in circulating tumor cells were associated with clinical outcomes and resistance to hormone therapy in patients with mCRPC.